Key Discovery Milestones With active concentrations in the nanomolar range (10 M) and a safety margin 300-fold above therapeutic doses, GHK-Cu combines potent biological activity with an excellent safety profile established through decades of clinical use and research studies published in peer-reviewed journals like PubMed
Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Boehringer M, Loesche W, et al
Whats the connection between BPC 157 and GHRP (Growth Hormone Release peptides)
It does not provide medical advice, dosing instructions, or a recommendation for human use
With no head-to-head study, comparing the two requires stitching together trials that differ in population, comparator, endpoint, and duration a chain with several weak links